[0xWTF]

3M-052 again? Oh, for fuck's sake. We've been down this road for 15 years now. Every funder who learns about the interferon cascade gets a boner. And then they go to animal trials and meet disappointment. If these guys can get to an IND, good on them, but 3M is really licensing the shit out of this one.

Meanwhile, if you've got spare millions laying around, have a look at ENA Respiratory. They've already done a Phase 1 in Australia (entirely admissable for the FDA). Turns out hypoxia creates and anxiety and old people have most of the world's wealth, so COPD is a lucrative market.

Another super interesting one is Lumen Biosciences - can't make oil from algae at a viable price point, but for sure they can hit pharma price points, even food supplement price points.